Cargando…
The role of botulinum toxin type A related axon transport in neuropathic pain induced by chronic constriction injury
BACKGROUND: The mechanism of peripheral axon transport in neuropathic pain is still unclear. Chemokine ligand 13 (CXCL13) and its receptor (C-X-C chemokine receptor type 5, CXCR5) as well as GABA transporter 1 (GAT-1) play an important role in the development of pain. The aim of this study was to ex...
Autores principales: | Bu, Huilian, Jiao, Pengfei, Fan, Xiaochong, Gao, Yan, Zhang, Lirong, Guo, Haiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Pain Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530680/ https://www.ncbi.nlm.nih.gov/pubmed/36175338 http://dx.doi.org/10.3344/kjp.2022.35.4.391 |
Ejemplares similares
-
Botulinum Toxin for Central Neuropathic Pain
por: Park, Jihye, et al.
Publicado: (2018) -
Botulinum Toxin for the Treatment of Neuropathic Pain
por: Park, JungHyun, et al.
Publicado: (2017) -
Botulinum Toxin for Neuropathic Pain: A Review of the Literature
por: Oh, Hyun-Mi, et al.
Publicado: (2015) -
Botulinum toxin type A for neuropathic pain in patients with spinal cord injury
por: Han, Zee‐A, et al.
Publicado: (2016) -
Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation
por: Intiso, Domenico, et al.
Publicado: (2015)